Kidney Failure, Chronic Clinical Trials

12 recruiting

Kidney Failure, Chronic Trials at a Glance

13 actively recruiting trials for kidney failure, chronic are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Calgary, London, and Aurora. Lead sponsors running kidney failure, chronic studies include Centre Hospitalier Departemental Vendee, Duke-NUS Graduate Medical School, and Alessandro Doria.

Browse kidney failure, chronic trials by phase

Treatments under study

About Kidney Failure, Chronic Clinical Trials

Looking for clinical trials for Kidney Failure, Chronic? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Failure, Chronic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Failure, Chronic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

International (Pediatric) Peritoneal Biobank

HealthyKidney Failure, ChronicTransplantation+1 more
Heidelberg University500 enrolled26 locationsNCT01893710
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Phase 3

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Diabetic NephropathiesKidney Failure, Chronic
Alessandro Doria150 enrolled19 locationsNCT06217302
Recruiting
Not Applicable

Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice'

Kidney Failure, Chronic Therapy; Hemodialysis
Duke-NUS Graduate Medical School100 enrolled1 locationNCT07309367
Recruiting
Not Applicable

DIALysis With EXpanded Solute Removal

Kidney DiseaseChronic Kidney Disease Requiring HemodialysisHemodialysis+5 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4,800 enrolled1 locationNCT06660277
Recruiting
Not Applicable

First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients

Chronic Kidney DiseasesRenal Insufficiency, ChronicKidney Failure, Chronic
UMC Utrecht12 enrolled3 locationsNCT06314503
Recruiting
Not Applicable

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

Kidney Failure, ChronicHyperphosphatemia
The University of Queensland3,600 enrolled115 locationsNCT03573089
Recruiting
Phase 1Phase 2

Empagliflozin in ESKD - A Feasibility Study

Heart FailureKidney Failure, Chronic
University of Mississippi Medical Center24 enrolled2 locationsNCT05687058
Recruiting
Phase 1Phase 2

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients

Cardiovascular Diseases (CVD)Kidney Failure, ChronicMalnutrition-Inflammation Syndrome+1 more
Mansoura University46 enrolled1 locationNCT06903559
Recruiting

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Kidney DiseasesDiabetic NephropathyKidney Failure, Chronic+2 more
The Rogosin Institute2,000 enrolled1 locationNCT01802034
Recruiting
Not Applicable

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

HemodialysisOxidative StressKidney Failure, Chronic
Universidade Federal Fluminense30 enrolled1 locationNCT06438445
Recruiting
Phase 4

Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients

Kidney Failure, Chronic
Centre Hospitalier Departemental Vendee30 enrolled2 locationsNCT03640026
Recruiting

Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP)

Kidney Failure, Chronic
Université de Sherbrooke15 enrolled1 locationNCT05968391